Results
|
8021.
|
|
|
8022.
|
|
|
8023.
|
|
|
8024.
|
|
|
8025.
|
|
|
8026.
|
|
|
8027.
|
|
|
8028.
|
|
|
8029.
|
|
|
8030.
|
|
|
8031.
|
|
|
8032.
|
|
|
8033.
|
|
|
8034.
|
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer. [electronic resource] by
- Collins, Kyla A L
- Stuhlmiller, Timothy J
- Zawistowski, Jon S
- East, Michael P
- Pham, Trang T
- Hall, Claire R
- Goulet, Daniel R
- Bevill, Samantha M
- Angus, Steven P
- Velarde, Sara H
- Sciaky, Noah
- Oprea, Tudor I
- Graves, Lee M
- Johnson, Gary L
- Gomez, Shawn M
Publication details: Oncotarget Mar 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
8035.
|
|
|
8036.
|
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study. [electronic resource] by
- Fujimura, Taku
- Sato, Yota
- Tanita, Kayo
- Kambayashi, Yumi
- Otsuka, Atsushi
- Fujisawa, Yasuhiro
- Yoshino, Koji
- Matsushita, Shigeto
- Funakoshi, Takeru
- Hata, Hiroo
- Yamamoto, Yuki
- Uchi, Hiroshi
- Nonomura, Yumi
- Tanaka, Ryota
- Aoki, Megumi
- Imafuku, Keisuke
- Okuhira, Hisako
- Furudate, Sadanori
- Hidaka, Takanori
- Aiba, Setsuya
Publication details: Oncotarget Mar 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
8037.
|
|
|
8038.
|
|
|
8039.
|
|
|
8040.
|
|